Home
About Us
Information
Research
Products
News
Purchase
Contact
Sitemap
Sitemap
Home
About Us
Vision
Management
Advisory Board
Information
Vodcasts
Marianne Liefers,
The Netherlands
Claudine Deprest,
Belgium
Testimonials
Downloads
Research
Technology
BESTIPP Study
Ongoing Studies
Products
KFH Energy
Other
News
Purchase
Contact
Sitemap
Chronic-conditions-endurance
Chronic-conditions-fatigue
Fibromyalgia
Chronic-conditions-multiple-sclerosis
Chronic-conditions-pain
Post polio
Chronic-conditions-venous-leg-ulcers
NL
|
DE
|
FR
News
Kingfisher Healthcare (KFH) wins prestigious Frost & Sullivan Best Practices Award
(09/06/2008)
KFH has announced that it has been awarded the prestigious Emerging Company of the Year 2008, in the European Pain and Wound Management category.
Kingfisher Healthcare (KFH) receives FDA clearance to market KFH Energy in the USA
(31/03/2008)
Leuven, Belgium, March 31, 2008 - Kingfisher Healthcare, a young healthcare company focused on improving patient quality of life, announced today that the U.S. Food and Drug Administration (FDA) has granted the company 510(k) clearance to market KFH Energy in the United States. The patented, high-tech medical device is designed to alleviate fatigue and pain and has received the CE mark in Europe in September 2007.
Kingfisher Healthcare (KFH) launches innovative technology for wound healing in Europe
(11/03/2008)
KFH has today announced the European launch of KFH Novo, a new and innovative product to address the major problem of chronic wounds. KFH Novo is a patented, high-tech medical device that is non-invasive, and can be used without interfering with standard conventional therapy.
© Kingfisher Healthcare NV
Interleuvenlaan 62, 3001 Leuven
T. +32 (16) 39 78 36
F. +32 (16) 39 78 41
Home
|
About Us
|
Information
|
Research
|
Products
|
News
|
Purchase
|
Contact
|
Sitemap
Terms and Conditions
Privacy Policy
Webdesign Vector BROSS
